Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)

NCT05444348

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +20 more
Locations
  • Aalborg Universitetshospital Aalborg, Denmark
  • Aarhus Universitetshospital Aarhus, Denmark
  • Sydvestjysk sygehus - Esbjerg Esbjerg, Denmark
  • Regionshospitalet Gødstrup Herning, Denmark
View Trial Details
Recruiting

Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections

NCT07220915

Conditions
Agammaglobulinemia, Autoimmune Conditions, Blood Protein Disorders, +9 more
Locations
  • Perseverance Research Center, Phoenix Neurological Associates Scottsdale, Arizona, United States
  • UMHAT Sveti Georgi EAD Plovdiv, Bulgaria
  • P. Stradins Clinical University Hospital Riga, Latvia
  • Riga East Clinical University Hospital Riga, Latvia
View Trial Details
Recruiting

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

NCT06651177

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Gateway Community Services Jacksonville, Florida, United States
  • IBIS Behavioral Health Tampa, Florida, United States
  • Ruth M. Rothstein CORE Center Chicago, Illinois, United States
  • The Gibson Center for Behavioral Change Cape Girardeau, Missouri, United States
View Trial Details
Recruiting

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

NCT07342478

Conditions
CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +23 more
Locations
  • The Center for Cancer and Blood Disorders-Bethesda Bethesda, Maryland, United States
  • Optum Medical Group (Rhodes) P.C. Las Vegas, Nevada, United States
  • OSU Comprehensive Cancer Center Columbus, Ohio, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .

NCT07191249

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Rambam Health Care Campus Haifa, Israel
  • Shaare Zedek Medical Center Jerusalem, Israel
  • The Hadassah University Hospital-Ein Kerem Jerusalem, Israel
  • Tel Aviv Sourasky Medical Center (TASMC) - Ichilov Tel Aviv, Israel
View Trial Details

Related conditions